| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.68M | 420.57M | 390.63M | 378.48M | 267.95M | 260.59M |
| Gross Profit | 81.28M | 219.23M | 209.08M | 219.64M | 144.85M | 132.63M |
| EBITDA | -191.47M | -50.52M | 154.60M | 167.29M | 104.91M | 93.93M |
| Net Income | -201.56M | -53.72M | 19.24M | 18.66M | 3.15M | 77.81M |
Balance Sheet | ||||||
| Total Assets | 505.48M | 478.23M | 201.04M | 162.94M | 131.35M | 81.36M |
| Cash, Cash Equivalents and Short-Term Investments | 127.36M | 77.46M | 41.22M | 13.64M | 21.94M | 13.42M |
| Total Debt | 0.00 | 205.53M | 350.86M | 375.37M | 398.07M | 255.89M |
| Total Liabilities | 353.01M | 621.68M | 406.81M | 454.94M | 539.00M | 273.91M |
| Stockholders Equity | 152.47M | -143.45M | -802.36M | -892.23M | -1.02B | -192.55M |
Cash Flow | ||||||
| Free Cash Flow | 23.99M | 120.04M | 93.37M | 83.73M | 73.03M | 79.56M |
| Operating Cash Flow | 26.27M | 127.45M | 104.31M | 92.78M | 77.78M | 87.06M |
| Investing Cash Flow | -65.12M | -9.95M | -10.94M | -9.05M | -4.75M | -7.50M |
| Financing Cash Flow | 118.24M | -81.26M | -65.79M | -92.03M | -64.51M | -92.87M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $3.67B | 11.55 | 27.38% | 0.67% | 1.55% | 701.41% | |
70 Outperform | $1.24B | 84.64 | 2.21% | ― | 2.82% | -34.29% | |
70 Outperform | $2.64B | 25.10 | 11.31% | 1.27% | 7.43% | 148.83% | |
66 Neutral | $627.09M | 13.31 | 13.77% | 3.49% | 22.39% | 112.75% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $373.86M | 32.95 | 5.06% | ― | -12.38% | -0.71% | |
60 Neutral | $7.09B | -10.44 | ― | ― | -61.71% | -622.81% |
On January 14, 2026, CompoSecure, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to a previously filed shelf registration statement to facilitate the resale of 161,034,417 shares of its common stock by certain existing stockholders. The filing, which incorporates a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP, effectively provides a registered pathway for these shareholders to sell their holdings, potentially increasing the stock’s trading float without directly raising new capital for the company.
The most recent analyst rating on (CMPO) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On January 14, 2026, CompoSecure announced it had refinanced approximately $2.1 billion of debt following the completion of its combination with Husky Technologies Limited on January 13, 2026, using a mix of $900 million of new 5.625% senior secured notes due 2033, a new $1.2 billion term loan facility maturing in 2033, and $400 million in revolving credit commitments maturing in 2031. The proceeds from these transactions, together with borrowings under the new senior credit facilities, were used to refinance Husky’s existing indebtedness under its prior credit agreement, pay related fees and expenses, and redeem in full Husky’s previously outstanding $1.0 billion of 9.000% senior secured notes for approximately $1.04 billion, after which those notes were no longer outstanding. The new notes and credit facilities, all senior secured and subject to customary covenants and leverage-based conditions, extend CompoSecure’s debt maturities, replace higher-cost legacy Husky financing, and provide significant revolving capacity, improving the combined company’s capital structure and flexibility while imposing leverage and covenant disciplines that will shape its financial policy going forward.
The most recent analyst rating on (CMPO) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On January 12, 2026, CompoSecure completed its business combination with Husky Technologies, creating a $7.4 billion diversified platform with roughly 70% recurring revenues, and rebranded its corporate entity as GPGI, Inc., which will report through two segments, CompoSecure and Husky, while its shares are expected to begin trading on the NYSE under the ticker GPGI on January 23, 2026. In connection with the transaction, the company overhauled its capital structure and governance by issuing more than 161 million new common shares to Platinum-affiliated parties and PIPE investors in private placements, assuming and moving to refinance over $3.1 billion of Husky debt while repaying and terminating a $330 million legacy credit facility, granting Platinum’s affiliate PE Titan CS Holdings board nomination and registration rights, appointing Platinum executives Louis Samson and Delara Zarrabi to the board, and installing a long-term management agreement under which Resolute Holdings will manage the Husky business for a fee tied to adjusted EBITDA, collectively cementing GPGI’s status as a permanent capital compounder backed by institutional sponsors and the David Cote family’s retained $1 billion equity stake.
The most recent analyst rating on (CMPO) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On November 2, 2025, CompoSecure, Inc. entered into a Share Purchase Agreement with Husky Technologies Limited and other parties, involving a combination valued at approximately $3.953 billion in cash and shares. Concurrently, CompoSecure agreed to a private placement of shares for about $1.96 billion. The company has faced legal challenges from shareholders alleging incomplete and misleading information in its Proxy Statement, which could affect the approval of the transaction at the upcoming special meeting on December 23, 2025. To mitigate risks and costs of litigation, CompoSecure has decided to voluntarily supplement the Proxy Statement, although it denies any wrongdoing.
The most recent analyst rating on (CMPO) stock is a Hold with a $21.50 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On November 2, 2025, CompoSecure, Inc. announced a Share Purchase Agreement with Husky Technologies Limited and its affiliates, valued at approximately $3.953 billion in cash and shares. This transaction will result in Husky becoming an indirect wholly owned subsidiary of CompoSecure. The agreement is subject to several closing conditions, including shareholder approval and regulatory clearances. The transaction is expected to enhance CompoSecure’s market position and operational capabilities, with potential implications for stakeholders, such as changes in the company’s board and management agreements.
The most recent analyst rating on (CMPO) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On November 3, 2025, CompoSecure, Inc. announced the redemption of all its outstanding public warrants to purchase shares of its Class A common stock. The redemption date is set for December 3, 2025, and warrant holders have until that date to exercise their warrants on a cashless basis. Any unexercised warrants will be canceled, and holders will receive $0.01 per warrant. This move follows the company’s right to redeem the warrants as the stock price met certain criteria, potentially impacting stakeholders by altering their rights and investment strategies.
The most recent analyst rating on (CMPO) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.
On November 3, 2025, CompoSecure announced its strong financial results for the third quarter of 2025, with significant growth in net sales and gross profit compared to the previous year. The company also revealed a business combination with Husky Technologies, a manufacturer of engineered equipment, valuing the combined entity at approximately $7.4 billion. This strategic move aims to enhance CompoSecure’s market position and create new opportunities for growth. The transaction is expected to close in the first quarter of 2026 and is anticipated to be accretive to earnings per share in the first full year post-closing.
The most recent analyst rating on (CMPO) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on CompoSecure stock, see the CMPO Stock Forecast page.